Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

Medical Care Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural... see more

Recent & Breaking News (CSE:PHRX)

PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine

Newsfile 9 days ago

PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine

Newsfile March 13, 2024

PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman

Newsfile February 27, 2024

PharmaTher's Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated Cepharanthine for Phase 1 Study in Australia

GlobeNewswire February 21, 2024

PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies

Newsfile February 14, 2024

PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers

Newsfile February 12, 2024

PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement

Newsfile February 8, 2024

PharmaDrug Inc. Announces Proposed Non-Brokered Private Placement

Newsfile February 1, 2024

PharmaDrug CEO Provides Vision for Securedose Acquisition

Newsfile December 13, 2023

PharmaDrug Inc. Completes Debt Restructuring

Newsfile November 15, 2023

PharmaDrug Inc. Announces Grant of Stock Options

Newsfile November 8, 2023

PharmaDrug Inc. Closes Acqusition of Securedose Synthetics

Newsfile November 7, 2023

PharmaDrug Inc. Enters Definitive Agreement to Acquire SecureDose Synthetics

Newsfile October 27, 2023

PharmaDrug Announces Share Consolidation and Change to Chief Financial Officer

Newsfile October 20, 2023

PharmaDrug Announces Amendment to Shareholder Meeting Matter

Newsfile September 19, 2023

PharmaDrug Provides Development Update of Cepharanthine (PD-001) for Cancer and Infectious Disease

Newsfile September 14, 2023

PharmaDrug Announces Appointment of CEO and Changes to the Board of Directors

Newsfile September 6, 2023

PharmaDrug Announces Strategic Investment in Sairiyo Therapeutics Inc.

Newsfile July 18, 2023

PharmaDrug Announces Termination of General Security Agreement and Issuance of Common Shares

Newsfile July 5, 2023

PharmaDrug Brings On Advisor to Maximize Shareholder Value With Its Underlying Assets

Newsfile May 23, 2023